# Intervention to Hepatic and Pulmonary Metastasis in Breast Cancer Patients

> **NCT02251353** · — · UNKNOWN · sponsor: **Federation of Breast Diseases Societies** · enrollment: 300 (estimated)

## Conditions studied

- Breast Cancer
- Metastasis

## Interventions

- **PROCEDURE:** intervention
- **DRUG:** systemic treatment

## Key facts

- **NCT ID:** NCT02251353
- **Lead sponsor:** Federation of Breast Diseases Societies
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-06
- **Primary completion:** 2020-06
- **Final completion:** 2022-06
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2020-02-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02251353

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02251353, "Intervention to Hepatic and Pulmonary Metastasis in Breast Cancer Patients". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02251353. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*